Biomarkers and personalized risk stratification for patients with clinically localized prostate cancer
Author:
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Oncology
Link
http://www.tandfonline.com/doi/pdf/10.1586/14737140.2014.952288
Reference99 articles.
1. Cancer statistics, 2014
2. Prostate cancer: from the pathophysiologic implications of some genetic risk factors to translation in personalized cancer treatments
3. Risk stratification in prostate cancer screening
4. Prostate cancer diagnosis in the new millennium: strengths and weaknesses of prostate-specific antigen and the discovery and clinical evaluation of prostate cancer gene 3 (PCA3)
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A Novel Modality Enables New Evidence-Based Individual Risk Stratification That Can Potentially Lead to Decisive Management and Treatment Decisions in Prostate Cancer;Diagnostics;2023-01-24
2. Inhibitors targeting epigenetic modifications in cancer;Transcription and Translation in Health and Disease;2023
3. Can epigenetic and inflammatory biomarkers identify clinically aggressive prostate cancer?;World Journal of Clinical Oncology;2020-02-24
4. Oxidative stress and redox signaling in CRPC progression: therapeutic potential of clinically-tested Nrf2-activators;Cancer Drug Resistance;2020
5. MiR-193b promoter methylation accurately detects prostate cancer in urine sediments and miR-34b/c or miR-129-2 promoter methylation define subsets of clinically aggressive tumors;Molecular Cancer;2017-01-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3